Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-3. Biologic effects and clinical impact.

W Oster1, J Frisch, U Nicolay

  • 1Clinical Research Immunology/Oncology Department, Behringwerke AG, Marburg, Germany.

Cancer
|May 15, 1991
PubMed
Summary

Human interleukin-3 (IL-3), a protein stimulating multiple blood cell types, was tested in clinical trials. This report summarizes early findings on IL-3

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging invasive mussel contaminant survey data for stepwise prioritization of chemicals of potential concern in the Great Lakes basin.

Environmental toxicology and chemistry·2025
Same author

Urinary diversion and quality of life: A six-year follow-up study of bladder cancer surgery.

Actas urologicas espanolas·2025
Same author

[Deployment of the in-hospital emergency team in a tertiary care university hospital : Data analysis for the time period 2013-2016 in North-Rhine/Westphalia].

Der Anaesthesist·2019
Same author

Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder.

International urology and nephrology·2017
Same author

Multiple cytokines for the detection of <i>Mycobacterium tuberculosis</i> infection in children with tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
Same author

rAAV-mediated overexpression of sox9, TGF-β and IGF-I in minipig bone marrow aspirates to enhance the chondrogenic processes for cartilage repair.

Gene therapy·2015

Area of Science:

  • Hematology
  • Immunology
  • Biotechnology

Background:

  • Human interleukin-3 (IL-3) is a key cytokine for hematopoietic stem cell proliferation and differentiation.
  • IL-3 supports multiple myeloid lineages, including neutrophils, eosinophils, basophils, and monocytes.
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) shares overlapping biological activities and binding characteristics with IL-3.

Purpose of the Study:

  • To summarize clinical experiences with human interleukin-3 (IL-3) in early-phase trials.
  • To evaluate the safety and efficacy of IL-3, both as a single agent and in combination with GM-CSF.

Main Methods:

  • Recombinant human IL-3 expressed in yeast was utilized.
  • Phase I/II clinical trials were conducted to assess IL-3 therapy.
  • Data from patients receiving IL-3 alone or with GM-CSF were analyzed.

Main Results:

  • Human IL-3 demonstrated specific activity of 5 x 10(7) U/mg.
  • IL-3 exhibited functional and proliferative effects on various hematopoietic cell lineages.
  • Clinical trial data on IL-3 and IL-3/GM-CSF combinations were compiled.

Conclusions:

  • IL-3 is a potent hematopoietic growth factor with potential therapeutic applications.
  • Early clinical trials provide insights into the use of IL-3 in hematological conditions.
  • Combination therapy with GM-CSF warrants further investigation.

Related Experiment Videos